IPO Premiums
IPO calendar
EHListed

Entero Healthcare Solutions Limited

Book Built Issue IPO · NSE, BSE

Price band
₹1195 - ₹1258
Lot size
11 shares
Issue amount
₹1,600 cr
Total subscription
1.56×
Current price₹1,503.9
Listing price ₹1,228.7
Watch live price ↗
Opens
9 Feb 2024
Closes
13 Feb 2024
Allotment
14 Feb 2024
Listing
16 Feb 2024

Offer at a glance

Issue overview

Issue size
1,27,18,600 shares
Face value
₹10 Per Equity Share
Minimum investment
₹13,145
Fresh issue
₹1,000 cr
Offer for sale
₹600 cr
Registrar
Link Intime India Private Limited
Listing exchange
NSE, BSE
Maximum investment
₹13,838
Issue type
Book Built Issue IPO
Shares before issue
1,60,66,886
Shares after issue
2,40,16,011

Lot sizes

CategoryLotsSharesAmount
RETAIL111₹13,838
sHNI15165₹2,07,570
bHNI73803₹10,10,174

Share reservation

Retail9.95%
NII(HNI)14.92%
QIB29.85%
Employees0.55%

Subscription & GMP

Subscription by category

Total subscribed1.56×

Missing multiples are calculated from bids and offered shares when available.

QIB2.29×
NIB0.22×
HNIs(10L +)0.17×
HNIs (2-10L)0.34×
RETAIL1.38×
EMPLOYEES1.33×

GMP history

01212 Mar: ₹220 Nov: ₹2
12 Mar₹220 Nov

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs477.61,092.72
RETAIL159.2219.38
NIB238.853.69
HNIs 2+79.626.78
HNIs 10+159.226.91
EMPLOYEES8.8411.71

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profit In Crores
-1,00001,0002,0003,0004,000Mar-21 · Revenue: 1,783.67Mar-21 · Profit after tax: -15.35Mar-21Mar-22 · Revenue: 2,526.55Mar-22 · Profit after tax: -29.44Mar-22Mar-23 · Revenue: 3,305.72Mar-23 · Profit after tax: -11.1Mar-23
RevenueProfit after tax

Key performance indicators

Metric202320222021
EPS9.700
ROE-2.66-7.35-4.23
ROCE6.051.491.88
RONW-1.86-5.23-3.15
PRE IPO(PE)-3.1500
POST IPO(PE)000

Values and labels as reported in the issue data.

Company information

Company profile

Entero Healthcare Solutions Limited was founded in 2018 and is a leading distributor of healthcare products in India. Using a technology-driven platform, the company supplies healthcare products to pharmacies, hospitals, and clinics across the country. Key Highlights: Growing Customer Base: Served 39,500+ retail customers in 2021, 64,200+ in 2022, and 81,400+ in 2023. Also served 1,600+ hospitals in 2021, 2,500+ in 2022, and 3,400+ in 2023. Strong Manufacturer Network: Partnered with 1,900+ healthcare product manufacturers, offering access to 64,500+ product SKUs (as of March 31, 2023). Extensive Infrastructure: Operates 73 warehouses in 37 cities across 19 states and union territories, covering 495 districts in India. Large Workforce: As of March 31, 2023, the company has 3,014 employees across various departments. With its vast distribution network and strong industry relationships, Entero Healthcare Solutions continues to expand its reach in the healthcare sector.

Strengths

  • Proprietary technology platform: Enhances operational efficiency and delivers better customer service.
  • Strong expansion record: Demonstrates steady growth in reach, revenue, and overall business scale.
  • Unique integrated model: Offers end-to-end commercial and supply chain solutions that set the company apart.
  • Experienced leadership team: Guided by seasoned promoters and skilled senior management for effective decision-making.

Risk factors

  • Past financial losses: Indicate potential instability and raise concerns about long-term sustainability.
  • High working capital requirements: Can strain financial resources and create cash flow pressure.
  • Competitive and consolidating industry: Market pressures may impact operations and reduce margins.
  • Negative cash flows: Pose challenges to maintaining financial stability and smooth operations.

Promoters

Prabhat Agrawal

Prem Sethi

OrbiMed Asia III Mauritius Limited

Registrar & documents

Lead manager

ICICI Securities Limited, Dam Capital Advisors Limited, Jefferies India Private Limited, Jm Financial Limited, SBI Capital Markets Limited

Registered office

Plot No. I-35, Building - B Industrial Area Phase - I 13/7 Mathura Road, Faridabad 121 003

+91 22-69019100

[email protected]Company website ↗

Frequently Asked Questions

What is Entero Healthcare Solutions IPO GMP today?

As of today, Entero Healthcare Solutions IPO Grey Market Premium (GMP) is reported at +₹2 per share. Based on the upper price band of ₹1,258, the estimated listing price is ₹1,260 (+0.2% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for Entero Healthcare Solutions IPO?

The minimum bid lot size for Entero Healthcare Solutions IPO is 11 shares. At the cut-off price of ₹1,258 per share, retail investors need a minimum application amount of ₹13,838 per lot. Retail applicants can apply for a maximum of 14 lots (up to ₹2,00,000).

When will Entero Healthcare Solutions IPO allotment status be announced?

The allotment status for Entero Healthcare Solutions IPO is scheduled to be finalized on 14 Feb 2024. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Link Intime India Private Limited's official portal or via BSE/NSE allotment portals.

How can I check Entero Healthcare Solutions IPO allotment status online by PAN?

To check Entero Healthcare Solutions IPO allotment status: 1) Visit the registrar portal (Link Intime India Private Limited) or the BSE IPO allotment page. 2) Select 'Entero Healthcare Solutions Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.
Entero Healthcare Solutions IPO GMP Today, Subscription Status & Allotment Date | IPO Premiums